Name

Address& e-mail

Scientific Field

Renato Iozzo

Department of Pathology, Anatomy & Cell Biology, Thomas Jefferson University

Philadelphia, USA

Proteoglycan, Cancer Biology,

Tumor Angiogenesis

Vincent Hascall

Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, USA

Hyaluronan in inflammatory pathologies

John Couchman

Dept. Biomedical Sciences, University of Copenhagen, Biocenter, Copenhagen, Denmark

Proteoglycans, cell adhesion, signalling, cytoskeleton

Hideaki Nagase

Matrix Biology, Kennedy Institute of Rheumatology, University of Oxford, UK

Endocytic regulation of matrix-degrading metalloproteinase activities

DimitrisKletsas

Laboratory of Cell proliferation &

Ageing, Institute of Biology, National

Centre for Scientific Research

"Demokritos", Athens, Greece

Age-related pathologies, ECM, growth factors, signaling pathways, stress, wound healing, cancer, stem cells and cell replacement therapy

Jan-Olof Winberg

Department of Medical Biology, Faculty of Medicine, University of Tromsø, Norway

Enzymology, enzyme kinetics, matrix metalloproteinases, short chain dehydrogenases

Liliana Schaefer

Pharmazentrum Frankfurt, Institutfür Allgemeine Pharmakologie und Toxikologie, Frankfurt am Main, Germany

SLRPs, signaling, inflammation, fibrosis, kidney

Donald Gullberg

Department of Biomedicine, University of Bergen, Norway

Cellular interactions with ECM, integrins, fibroblasts, fibrosis, tumor-stroma interactions

AchilleasTheocharis

Laboratory of Biochemistry, Department of Chemistry, University of Patras, Greece

Proteoglycans (serglycin) in multiple myeloma and cancer progression

Nikos Karamanos

Laboratory of Biochemistry, Department of Chemistry, University of Patras, Greece

Matrix Molecular Targets in Breast Cancer, Proteoglycans, Metalloproteinases,

ER cross-talk signaling

Paraskevi Heldin

Ludwig Institute for Cancer Research, Uppsala University, Biomedical Center, Uppsala, Sweden

Microenvironment in tumor progression, Hyaluronan and HAS signaling

Anna Blom

Lund University, Department of Laboratory Medicine Malmö, Division of Medical Protein Chemistry, Malmo, Sweden

Inflammation, innate immunity, protein chemistry, complement system, rheumatology

François-Xavier Maquart

Matrice Extracellulaire et Dynamique Cellulaire (MEDyC), Université de Reims- Champagne-Ardenne, Reims cedex France

Cell-extracellular matrix interactions

Alberto Passi

Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Universita degli Studi dell'Insubria, Varese, Italy

Extracellular matrix metabolism with specific emphasis on hyaluronan

Carl-Henrik Heldin

Ludwig Institute for Cancer Research, Uppsala University, Biomedical Center, Uppsala, Sweden

Signal transduction via PDGF receptors and TGFbeta receptors

Hideto Watanabe

Institute for Molecular Science of Medicine, Aichi Medical University, Yazakokarimata 1-1, Nagakute, Aichi, Japan

molecular pathobiology of the extracellular matrix proteoglycans

Katalin Dobra

Division of Clinical Pathology/Cytology

Department of Laboratory Medicine

Karolinska University Hospital Huddinge, Stockholm Sweden

Molecular biology and

Tumor biology

Ralph Sanderson

Dept. of Pathology, Univ. Alabama at Birmingham, Alabama 35294 USA

Heparan sulfate/tumor microenvironment,

Heparanase signaling

Martin Götte

Department of Gynecology and Obstetrics, Muenster University, Medical Center, Muenster,Germany

Extracellular matrix and miRNAs -Role in cancer and inflammation

Mauro Pavao

Program of Glycobiology, Institute of Medical Biochemistry, Federal University of Rio de Janeiro, Brazil

Heparin nanoparticles for pharmacological targeting

Karin Forsberg-Nilsson

Stem Cell Research, SciLifeLab

Dept of Immunology, Genetics and Pathology, Uppsala University, Sweden

neural stem cells, stem cell differentiation, brain tumor biology

Peter Friedl

Microscopical Imaging of the Cell, Dept. of Cell Biology, Nijmegen, The Netherlands

Microscopy, cell migration, cancer, immune cell, ECM

Jerry Turnbull

Dept. of Biochemistry, Institute of Integrative Biology, University of Liverpool, UK

Heparan sulfates; chemical biology, therapeutic applications

Mats Paulsson

Institute for Biochemistry, Medical Faculty

University of Cologne, Germany

ECM assembly and connective tissue disease

Boris Turk

Dept. Biochem. & Mol. & Struct. Biol.

J. Stefan Institute, Ljubljana, Slovenia

Protease biology, cell death

Veli-Matti Kähäri

Department of Dermatology, University of Turku, Finland

Proteinases, ECM, skin cancer, wound repair

Michael Elkin

Tumor Biology Reearch Unit, Dept. of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Tumor biology, heparanase, inflammation, extracellular matrix

Lena Kjellén

Department of Medical Biochemistry and Microbiology, The Biomedical Center, Uppsala, Sweden

GAGs biosynthesis. Role of HS in embryonic development studied in model organisms (mouse, zebrafish, C. elegans)

Marco Franci

Faculty of Sciences-University of Bologna, Italy

Collagen organization

Thomas N. Wight

Hope Heart Matrix Biology, Program Benaroya Research Institute

Seattle, University of Washington, USA

Proteoglycans in Inflammation-

Control of Cell Phenotype